Business
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced med...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December 11, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, December 11, 2025, at 8:30am ET.\n \n\n To view, listen to, and participate in the live webcast, please follow the link below:\n \n\n\n https://events.q4inc.com/attendee/516259946\n \n\n\n To listen and participate via the conference call, please dial:\n \n\n North American Toll-Free: 1-800-549-8228\n \n Local (Toronto): 289-819-1520\n \n Local (New York): 646-564-2877\n \n Conference ID: 57487\n \n\n Participants will be able to ask questions of Company management during the Q&A portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.\n \n\n A recording of the call will be available on\n \n www.covalon.com\n \n under News & Events on the Investors tab.\n \n\n Copies of Covalon’s financial statements and MD&A can be obtained on SEDAR PLUS at\n \n www.sedarplus.ca\n \n and under SEDAR Filings on the Investors tab of Covalon’s website.\n \n\n Those interested in learning about Covalon’s solutions may visit\n \n www.covalon.com\n \n or follow Covalon on\n \n LinkedIn\n \n ,\n \n Facebook\n \n ,\n \n Instagram\n \n , or\n \n X\n \n .\n \n\n\n About Covalon\n \n\n\n Covalon is a leading MedTech company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at\n \n www.covalon.com\n \n .\n \n\n\n Neither the TSX Venture Exchange nor its Regulation Services Provi...